1380P PK/PD analysis of pembrolizumab, nivolumab and atezolizumab in NSCLC patients: The PIONeeR trial Article Swipe

View

Joseph Ciccolini , Mourad Hamimed , Sophie Marolleau , Carlos Ayán Pérez , Sébastien Benzekry , Maryannick Le Ray , Arnaud Le Boyer , C. Audigier-Valette , S. Martinez , Hervé Pegliasco , Patrice Ray , L. Falchero , A Serre , N. Cloarec , Louisiane Lebas , S. Hominal , J. Mazieres , M. Pérol , L. Greillier , F. Barlesi ·

YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1016/j.annonc.2024.08.1435

Related Topics

Concepts

Atezolizumab Pembrolizumab Medicine Nivolumab Oncology Internal medicine Expanded access Immunotherapy Cancer

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1016/j.annonc.2024.08.1435
OA Status: green
Cited By: 1
Related Works: 10
OpenAlex ID: https://openalex.org/W4402560642

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4402560642

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1016/j.annonc.2024.08.1435

Digital Object Identifier
Title: 1380P PK/PD analysis of pembrolizumab, nivolumab and atezolizumab in NSCLC patients: The PIONeeR trial

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2024

Year of publication
Publication date: 2024-09-01

Full publication date if available
Authors: Joseph Ciccolini, Mourad Hamimed, Sophie Marolleau, Carlos Ayán Pérez, Sébastien Benzekry, Maryannick Le Ray, Arnaud Le Boyer, C. Audigier-Valette, S. Martinez, Hervé Pegliasco, Patrice Ray, L. Falchero, A Serre, N. Cloarec, Louisiane Lebas, S. Hominal, J. Mazieres, M. Pérol, L. Greillier, F. Barlesi

List of authors in order
Landing page: https://doi.org/10.1016/j.annonc.2024.08.1435

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: green

Open access status per OpenAlex
OA URL: https://inria.hal.science/hal-04824878

Direct OA link when available
Concepts: Atezolizumab, Pembrolizumab, Medicine, Nivolumab, Oncology, Internal medicine, Expanded access, Immunotherapy, Cancer

Top concepts (fields/topics) attached by OpenAlex
Cited by: 1

Total citation count in OpenAlex
Citations by year (recent): 2025: 1

Per-year citation counts (last 5 years)
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4402560642
doi	https://doi.org/10.1016/j.annonc.2024.08.1435
ids.doi	https://doi.org/10.1016/j.annonc.2024.08.1435
ids.openalex	https://openalex.org/W4402560642
fwci	0.53774674
type	article
title	1380P PK/PD analysis of pembrolizumab, nivolumab and atezolizumab in NSCLC patients: The PIONeeR trial
biblio.issue
biblio.volume	35
biblio.last_page	S867
biblio.first_page	S866
topics[0].id	https://openalex.org/T10158
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9997000098228455
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2730
topics[0].subfield.display_name	Oncology
topics[0].display_name	Cancer Immunotherapy and Biomarkers
topics[1].id	https://openalex.org/T11067
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9916999936103821
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	Colorectal Cancer Treatments and Studies
topics[2].id	https://openalex.org/T12172
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9836999773979187
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2730
topics[2].subfield.display_name	Oncology
topics[2].display_name	Neutropenia and Cancer Infections
is_xpac	False
apc_list.value	4060
apc_list.currency	USD
apc_list.value_usd	4060
apc_paid
concepts[0].id	https://openalex.org/C2775949291
concepts[0].level	5
concepts[0].score	0.9690070152282715
concepts[0].wikidata	https://www.wikidata.org/wiki/Q20707748
concepts[0].display_name	Atezolizumab
concepts[1].id	https://openalex.org/C2780057760
concepts[1].level	4
concepts[1].score	0.9402929544448853
concepts[1].wikidata	https://www.wikidata.org/wiki/Q13896859
concepts[1].display_name	Pembrolizumab
concepts[2].id	https://openalex.org/C71924100
concepts[2].level	0
concepts[2].score	0.934093713760376
concepts[2].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[2].display_name	Medicine
concepts[3].id	https://openalex.org/C2780030458
concepts[3].level	4
concepts[3].score	0.887056291103363
concepts[3].wikidata	https://www.wikidata.org/wiki/Q7041828
concepts[3].display_name	Nivolumab
concepts[4].id	https://openalex.org/C143998085
concepts[4].level	1
concepts[4].score	0.6164435148239136
concepts[4].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[4].display_name	Oncology
concepts[5].id	https://openalex.org/C126322002
concepts[5].level	1
concepts[5].score	0.5400434732437134
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[5].display_name	Internal medicine
concepts[6].id	https://openalex.org/C2775832928
concepts[6].level	2
concepts[6].score	0.4367107152938843
concepts[6].wikidata	https://www.wikidata.org/wiki/Q407954
concepts[6].display_name	Expanded access
concepts[7].id	https://openalex.org/C2777701055
concepts[7].level	3
concepts[7].score	0.2458713948726654
concepts[7].wikidata	https://www.wikidata.org/wiki/Q1427096
concepts[7].display_name	Immunotherapy
concepts[8].id	https://openalex.org/C121608353
concepts[8].level	2
concepts[8].score	0.1369204819202423
concepts[8].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[8].display_name	Cancer
keywords[0].id	https://openalex.org/keywords/atezolizumab
keywords[0].score	0.9690070152282715
keywords[0].display_name	Atezolizumab
keywords[1].id	https://openalex.org/keywords/pembrolizumab
keywords[1].score	0.9402929544448853
keywords[1].display_name	Pembrolizumab
keywords[2].id	https://openalex.org/keywords/medicine
keywords[2].score	0.934093713760376
keywords[2].display_name	Medicine
keywords[3].id	https://openalex.org/keywords/nivolumab
keywords[3].score	0.887056291103363
keywords[3].display_name	Nivolumab
keywords[4].id	https://openalex.org/keywords/oncology
keywords[4].score	0.6164435148239136
keywords[4].display_name	Oncology
keywords[5].id	https://openalex.org/keywords/internal-medicine
keywords[5].score	0.5400434732437134
keywords[5].display_name	Internal medicine
keywords[6].id	https://openalex.org/keywords/expanded-access
keywords[6].score	0.4367107152938843
keywords[6].display_name	Expanded access
keywords[7].id	https://openalex.org/keywords/immunotherapy
keywords[7].score	0.2458713948726654
keywords[7].display_name	Immunotherapy
keywords[8].id	https://openalex.org/keywords/cancer
keywords[8].score	0.1369204819202423
keywords[8].display_name	Cancer
language	en
locations[0].id	doi:10.1016/j.annonc.2024.08.1435
locations[0].is_oa	False
locations[0].source.id	https://openalex.org/S41454044
locations[0].source.issn	0923-7534, 1569-8041
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0923-7534
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Annals of Oncology
locations[0].source.host_organization	https://openalex.org/P4310320990
locations[0].source.host_organization_name	Elsevier BV
locations[0].source.host_organization_lineage	https://openalex.org/P4310320990
locations[0].source.host_organization_lineage_names	Elsevier BV
locations[0].license
locations[0].pdf_url
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Annals of Oncology
locations[0].landing_page_url	https://doi.org/10.1016/j.annonc.2024.08.1435
locations[1].id	pmh:oai:HAL:hal-04824878v1
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306402512
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	HAL (Le Centre pour la Communication Scientifique Directe)
locations[1].source.host_organization	https://openalex.org/I1294671590
locations[1].source.host_organization_name	Centre National de la Recherche Scientifique
locations[1].source.host_organization_lineage	https://openalex.org/I1294671590
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	info:eu-repo/semantics/other
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name	ISSN: 0923-7534
locations[1].landing_page_url	https://inria.hal.science/hal-04824878
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5088425379
authorships[0].author.orcid	https://orcid.org/0000-0003-1733-3410
authorships[0].author.display_name	Joseph Ciccolini
authorships[0].countries	FR
authorships[0].affiliations[0].institution_ids	https://openalex.org/I4210106545
authorships[0].affiliations[0].raw_affiliation_string	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
authorships[0].institutions[0].id	https://openalex.org/I4210106545
authorships[0].institutions[0].ror	https://ror.org/01nzkaw91
authorships[0].institutions[0].type	government
authorships[0].institutions[0].lineage	https://openalex.org/I1326498283, https://openalex.org/I201841394, https://openalex.org/I4210106545
authorships[0].institutions[0].country_code	FR
authorships[0].institutions[0].display_name	Research Centre Inria Sophia Antipolis - Méditerranée
authorships[0].author_position	first
authorships[0].raw_author_name	J. Ciccolini
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
authorships[1].author.id	https://openalex.org/A5035672550
authorships[1].author.orcid	https://orcid.org/0000-0002-4002-8230
authorships[1].author.display_name	Mourad Hamimed
authorships[1].countries	FR
authorships[1].affiliations[0].institution_ids	https://openalex.org/I4210106545
authorships[1].affiliations[0].raw_affiliation_string	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
authorships[1].institutions[0].id	https://openalex.org/I4210106545
authorships[1].institutions[0].ror	https://ror.org/01nzkaw91
authorships[1].institutions[0].type	government
authorships[1].institutions[0].lineage	https://openalex.org/I1326498283, https://openalex.org/I201841394, https://openalex.org/I4210106545
authorships[1].institutions[0].country_code	FR
authorships[1].institutions[0].display_name	Research Centre Inria Sophia Antipolis - Méditerranée
authorships[1].author_position	middle
authorships[1].raw_author_name	M. Hamimed
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
authorships[2].author.id	https://openalex.org/A5009225834
authorships[2].author.orcid	https://orcid.org/0009-0001-0764-4496
authorships[2].author.display_name	Sophie Marolleau
authorships[2].countries	FR
authorships[2].affiliations[0].institution_ids	https://openalex.org/I4210106545
authorships[2].affiliations[0].raw_affiliation_string	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
authorships[2].institutions[0].id	https://openalex.org/I4210106545
authorships[2].institutions[0].ror	https://ror.org/01nzkaw91
authorships[2].institutions[0].type	government
authorships[2].institutions[0].lineage	https://openalex.org/I1326498283, https://openalex.org/I201841394, https://openalex.org/I4210106545
authorships[2].institutions[0].country_code	FR
authorships[2].institutions[0].display_name	Research Centre Inria Sophia Antipolis - Méditerranée
authorships[2].author_position	middle
authorships[2].raw_author_name	S. Marolleau
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
authorships[3].author.id	https://openalex.org/A5010255015
authorships[3].author.orcid	https://orcid.org/0000-0001-5403-4220
authorships[3].author.display_name	Carlos Ayán Pérez
authorships[3].countries	FR
authorships[3].affiliations[0].institution_ids	https://openalex.org/I4210106545
authorships[3].affiliations[0].raw_affiliation_string	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
authorships[3].institutions[0].id	https://openalex.org/I4210106545
authorships[3].institutions[0].ror	https://ror.org/01nzkaw91
authorships[3].institutions[0].type	government
authorships[3].institutions[0].lineage	https://openalex.org/I1326498283, https://openalex.org/I201841394, https://openalex.org/I4210106545
authorships[3].institutions[0].country_code	FR
authorships[3].institutions[0].display_name	Research Centre Inria Sophia Antipolis - Méditerranée
authorships[3].author_position	middle
authorships[3].raw_author_name	C. Perez
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
authorships[4].author.id	https://openalex.org/A5063987547
authorships[4].author.orcid	https://orcid.org/0000-0002-3749-8637
authorships[4].author.display_name	Sébastien Benzekry
authorships[4].countries	FR
authorships[4].affiliations[0].institution_ids	https://openalex.org/I4210106545
authorships[4].affiliations[0].raw_affiliation_string	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
authorships[4].institutions[0].id	https://openalex.org/I4210106545
authorships[4].institutions[0].ror	https://ror.org/01nzkaw91
authorships[4].institutions[0].type	government
authorships[4].institutions[0].lineage	https://openalex.org/I1326498283, https://openalex.org/I201841394, https://openalex.org/I4210106545
authorships[4].institutions[0].country_code	FR
authorships[4].institutions[0].display_name	Research Centre Inria Sophia Antipolis - Méditerranée
authorships[4].author_position	middle
authorships[4].raw_author_name	S. Benzekry
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
authorships[5].author.id	https://openalex.org/A5108555667
authorships[5].author.orcid
authorships[5].author.display_name	Maryannick Le Ray
authorships[5].author_position	middle
authorships[5].raw_author_name	M. Le Ray
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5083665960
authorships[6].author.orcid	https://orcid.org/0000-0002-1904-1895
authorships[6].author.display_name	Arnaud Le Boyer
authorships[6].author_position	middle
authorships[6].raw_author_name	A. Boyer
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5078374653
authorships[7].author.orcid
authorships[7].author.display_name	C. Audigier-Valette
authorships[7].author_position	middle
authorships[7].raw_author_name	C. Audigier-Valette
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5043027923
authorships[8].author.orcid
authorships[8].author.display_name	S. Martinez
authorships[8].author_position	middle
authorships[8].raw_author_name	S. Martinez
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5004566780
authorships[9].author.orcid
authorships[9].author.display_name	Hervé Pegliasco
authorships[9].author_position	middle
authorships[9].raw_author_name	H. Pegliasco
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5053968717
authorships[10].author.orcid
authorships[10].author.display_name	Patrice Ray
authorships[10].author_position	middle
authorships[10].raw_author_name	P. Ray
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5005360063
authorships[11].author.orcid
authorships[11].author.display_name	L. Falchero
authorships[11].author_position	middle
authorships[11].raw_author_name	L. Falchero
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5111673714
authorships[12].author.orcid
authorships[12].author.display_name	A Serre
authorships[12].author_position	middle
authorships[12].raw_author_name	A. Serre
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5051567538
authorships[13].author.orcid
authorships[13].author.display_name	N. Cloarec
authorships[13].author_position	middle
authorships[13].raw_author_name	N. Cloarec
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5035811412
authorships[14].author.orcid
authorships[14].author.display_name	Louisiane Lebas
authorships[14].author_position	middle
authorships[14].raw_author_name	L. Lebas
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5082965263
authorships[15].author.orcid
authorships[15].author.display_name	S. Hominal
authorships[15].author_position	middle
authorships[15].raw_author_name	S. Hominal
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5060898363
authorships[16].author.orcid
authorships[16].author.display_name	J. Mazieres
authorships[16].author_position	middle
authorships[16].raw_author_name	J. Mazieres
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5043045128
authorships[17].author.orcid	https://orcid.org/0000-0002-3296-423X
authorships[17].author.display_name	M. Pérol
authorships[17].author_position	middle
authorships[17].raw_author_name	M. Pérol
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5016739453
authorships[18].author.orcid
authorships[18].author.display_name	L. Greillier
authorships[18].countries	FR
authorships[18].affiliations[0].institution_ids	https://openalex.org/I4210106545
authorships[18].affiliations[0].raw_affiliation_string	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
authorships[18].institutions[0].id	https://openalex.org/I4210106545
authorships[18].institutions[0].ror	https://ror.org/01nzkaw91
authorships[18].institutions[0].type	government
authorships[18].institutions[0].lineage	https://openalex.org/I1326498283, https://openalex.org/I201841394, https://openalex.org/I4210106545
authorships[18].institutions[0].country_code	FR
authorships[18].institutions[0].display_name	Research Centre Inria Sophia Antipolis - Méditerranée
authorships[18].author_position	middle
authorships[18].raw_author_name	L. Greillier
authorships[18].is_corresponding	False
authorships[18].raw_affiliation_strings	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
authorships[19].author.id	https://openalex.org/A5072763029
authorships[19].author.orcid
authorships[19].author.display_name	F. Barlesi
authorships[19].author_position	last
authorships[19].raw_author_name	F. Barlesi
authorships[19].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://inria.hal.science/hal-04824878
open_access.oa_status	green
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	1380P PK/PD analysis of pembrolizumab, nivolumab and atezolizumab in NSCLC patients: The PIONeeR trial
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10158
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9997000098228455
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2730
primary_topic.subfield.display_name	Oncology
primary_topic.display_name	Cancer Immunotherapy and Biomarkers
related_works	https://openalex.org/W3094946786, https://openalex.org/W2473036963, https://openalex.org/W4224282955, https://openalex.org/W2532961791, https://openalex.org/W3032782140, https://openalex.org/W2903848939, https://openalex.org/W2969038597, https://openalex.org/W4206430965, https://openalex.org/W4353088123, https://openalex.org/W2981548200
cited_by_count	1
counts_by_year[0].year	2025
counts_by_year[0].cited_by_count	1
locations_count	2
best_oa_location.id	pmh:oai:HAL:hal-04824878v1
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S4306402512
best_oa_location.source.issn
best_oa_location.source.type	repository
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l
best_oa_location.source.is_core	False
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	HAL (Le Centre pour la Communication Scientifique Directe)
best_oa_location.source.host_organization	https://openalex.org/I1294671590
best_oa_location.source.host_organization_name	Centre National de la Recherche Scientifique
best_oa_location.source.host_organization_lineage	https://openalex.org/I1294671590
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	submittedVersion
best_oa_location.raw_type	info:eu-repo/semantics/other
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	False
best_oa_location.is_published	False
best_oa_location.raw_source_name	ISSN: 0923-7534
best_oa_location.landing_page_url	https://inria.hal.science/hal-04824878
primary_location.id	doi:10.1016/j.annonc.2024.08.1435
primary_location.is_oa	False
primary_location.source.id	https://openalex.org/S41454044
primary_location.source.issn	0923-7534, 1569-8041
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0923-7534
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Annals of Oncology
primary_location.source.host_organization	https://openalex.org/P4310320990
primary_location.source.host_organization_name	Elsevier BV
primary_location.source.host_organization_lineage	https://openalex.org/P4310320990
primary_location.source.host_organization_lineage_names	Elsevier BV
primary_location.license
primary_location.pdf_url
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Annals of Oncology
primary_location.landing_page_url	https://doi.org/10.1016/j.annonc.2024.08.1435
publication_date	2024-09-01
publication_year	2024
referenced_works_count	0
abstract_inverted_index
cited_by_percentile_year.max	95
cited_by_percentile_year.min	91
countries_distinct_count	1
institutions_distinct_count	20
sustainable_development_goals[0].id	https://metadata.un.org/sdg/2
sustainable_development_goals[0].score	0.41999998688697815
sustainable_development_goals[0].display_name	Zero hunger
citation_normalized_percentile.value	0.67966462
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False